Respiri — Company Overview, News & Financial Data

Respiri (ASX:RSH) is a medical technology company that develops and commercialises medical devices for the diagnosis and management of respiratory diseases. The company’s flagship product, wheezo®, a simple sensor and mobile app, empowers home monitoring of wheeze, a key indicator in asthma and other respiratory conditions. wheezo® detects abnormal breath sounds and translates them into a "WheezeRate," offering valuable data for both patients and their doctors for proactive management and timely interventions. Respiri aims to revolutionise chronic respiratory disease management by demystifying wheezing, driving informed treatment decisions, and ultimately improving respiratory health outcomes.